ArticleClinical and experimental medicine2015

Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.

Kai Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.